Previous Close | 2.7300 |
Open | 2.6800 |
Bid | 2.5900 x 0 |
Ask | 2.6000 x 0 |
Day's Range | 2.5900 - 2.7500 |
52 Week Range | 2.1500 - 7.5000 |
Volume | |
Avg. Volume | 47,072 |
Market Cap | 240.143M |
Beta (5Y Monthly) | 1.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3930 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.50 |
Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, provides the following updates on its commercial agreements relating to its proprietary ZenGUARD™ antimicrobial coating.
Zentek Ltd.("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, has filed a provisional patent on the use of ZenGUARD™ as an anti-inflammatory agent for dermatological conditions. "We continue to work diligently to secure patents for our various intellectual property," said Greg Fenton, CEO for Zentek.
GUELPH, ON / ACCESSWIRE / July 5, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Ilse Treurnicht to its Board of Directors.